MBVKX
Price
$18.52
Change
-$0.45 (-2.37%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

MBVKX vs RMFCX

Header iconMBVKX vs RMFCX Comparison
Open Charts MBVKX vs RMFCXBanner chart's image
BlackRock Large Cap Focus Value K
Price$18.52
Change-$0.45 (-2.37%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
MBVKX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MBVKX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBVKX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. MBVKX (1.8B). MBVKX pays higher dividends than RMFCX: MBVKX (2.04) vs RMFCX (1.69). MBVKX was incepted earlier than RMFCX: MBVKX (10 years) vs RMFCX (23 years). MBVKX is a more actively managed with annual turnover of: 80.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than MBVKX: RMFCX (250) vs MBVKX (5000000). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. MBVKX (6.84). RMFCX return over 5 years is better than : 40.39 vs. MBVKX (0.89).
MBVKXRMFCXMBVKX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years23 years-
Gain YTD4.93811.42343%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.8B98.7B2%
Annual Yield % from dividends2.041.69120%
Returns for 1 year6.8412.6354%
Returns for 3 years7.3314.1652%
Returns for 5 years0.8940.392%
Returns for 10 yearsN/A61.84-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc